Science’s COVID-19 reporting is supported by the Heising-Simons Foundation.A rare but very serious side effect that has complicated Europe’s COVID-19 vaccination schedules for the past month has now thrown a wrench into U.S.
immunization efforts as well. In a joint statement on Tuesday morning, the U.S. Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) announced they were “recommending a pause” in the use of the COVID-19 vaccine made by Johnson & Johnson (J&J) “out of an abundance of caution.”The move came after six cases of a rare clotting disorder, also seen in some people vaccinated with AstraZeneca’s vaccine, were reported among more than 6.8 million people vaccinated with the J&J vaccine in the.